The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Abstract
Besides the common receptor/coreceptor‐dependent mechanism of cellular attachment, some viruses rely on antiviral antibodies for their efficient entry into target cells. This mechanism, known as antibody‐dependent enhancement (ADE) of viral infection, depends on the cross‐linking of complexes of virus–antibody or virus–activated complement components through interaction with cellular molecules such as Fc receptors or complement receptors, leading to enhanced infection of susceptible cells. Recent studies have suggested that additional mechanisms underlie ADE: involvement of complement component C1q and its receptor (Ebola virus), antibody‐mediated modulation of the interaction between viral protein and its coreceptor (human immunodeficiency virus) and suppression of cellular antiviral genes by the replication of viruses entering cells via ADE (Ross River virus). Since ADE is exploited by a variety of viruses and has been associated with disease exacerbation, it may have broad relevance to the pathogenesis of viral infection and antiviral strategies. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family
Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,100
A Prospective Study of Dengue Infections in Bangkok
Burke, D. S., Nisalak, A., Johnson, D. E., & Scott, R. M. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.172 · Cited by 828
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804
RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILAND
SANGKAWIBHA, N., ROJANASUPHOT, S., AHANDRIK, S., VIRIYAPONGSE, S., JATANASEN, S., SALITUL, V., PHANTHUMACHINDA, B., & HALSTEAD, S. B. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113932 · Cited by 716
Antibody-enhanced dengue virus infection in primate leukocytes
HALSTEAD, S. B., & O'ROURKE, E. J. (1977) · Nature · doi:10.1038/265739a0 · Cited by 550
Antibody-Enhanced Infection by HIV-1 Via Fc Receptor-Mediated Entry
Takeda, A., Tuazon, C. U., & Ennis, F. A. (1988) · Science · doi:10.1126/science.2972065 · Cited by 460
In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody
Halstead, S. B. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.527 · Cited by 438
Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic Cascade
Halstead, S. B. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s830 · Cited by 433
Dunn, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91624-x · Cited by 415
ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
Robinson, W. E., Montefiori, D., & Mitchell, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91657-1 · Cited by 358
Dengue Hemorrhagic Fever in Cuba, 1981: A Retrospective Seroepidemiologic Study
Guzmán, M. G., Kouri, G. P., Bravo, J., Soler, M., Vazquez, S., & Morier, L. (1990) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1990.42.179 · Cited by 348
The Fc and not CD4 Receptor Mediates Antibody Enhancement of HIV Infection in Human Cells
Homsy, J., Meyer, M., Tateno, M., Clarkson, S., & Levy, J. A. (1989) · Science · doi:10.1126/science.2786647 · Cited by 330
Antibody-Dependent Enhancement of Infection and the Pathogenesis of Viral Disease
Morens, D. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.3.500 · Cited by 317
Kurane, I., Innis, B. L., Nimmannitya, S., Nisalak, A., Meager, A., Janus, J., & Ennis, F. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115457 · Cited by 312
Sullivan, N., Sun, Y., Li, J., Hofmann, W., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4413-4422.1995 · Cited by 292
Mason, P. W., Rieder, E., & Baxt, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1932 · Cited by 254
Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue Tropism
Sixbey, J. W., & Yao, Q.-Y. (1992) · Science · doi:10.1126/science.1312750 · Cited by 221
Antibody-Dependent Enhancement of Ebola Virus Infection
Takada, A., Feldmann, H., Ksiazek, T. G., & Kawaoka, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7539-7544.2003 · Cited by 206
Self-citationAntibody-Dependent Enhancement of Viral Infectivity
Porterfield, J. S. (1986) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60268-7 · Cited by 202
Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines
Peiris, J. S. M., & Porterfield, J. S. (1979) · Nature · doi:10.1038/282509a0 · Cited by 201
Olsen, C. W., Corapi, W. V., Ngichabe, C. K., Baines, J. D., & Scott, F. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.956-965.1992 · Cited by 179
Homsy, J., Meyer, M., & Levy, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1437-1440.1990 · Cited by 155
Kurane, I., Meager, A., & Ennis, F. A. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.3.763 · Cited by 150
Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages
Peiris, M. J. S., Gordon, S., Unkeless, J. C., et al. (1981) · Nature · doi:10.1038/289189a0 · Cited by 142
Sullivan, N. J., Sun, Y., Binley, J. Μ., Lee, J., Barbas, C. F., Parren, P. W. H. I., Burton, D. R., & Sodroski, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6332-6338.1998 · Cited by 130
Chanas, A. C., Gould, E. A., Clegg, J. C. S., et al. (1982) · Journal of General Virology · doi:10.1099/0022-1317-58-1-37 · Cited by 129
Morens, D. M., & Halstead, S. B. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-12-2909 · Cited by 121
Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein
Takada, A., Watanabe, S., Okazaki, K., Kida, H., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2324-2330.2001 · Cited by 116
Self-citationMason, P. W., Baxt, B., Brown, F., Harber, J. J., Murdin, A. D., & Wimmer, E. (1993) · Virology · doi:10.1006/viro.1993.1073 · Cited by 111
We, R., Montefiori, D. C., Dh, G., & Wm, M. (1989) · PubMed · Cited by 111
Robinson, W. E., Montefiori, D. C., Mitchell, W. M., Prince, A. M., Alter, H. J., Dreesman, G. R., & Eichberg, J. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4710 · Cited by 108
Mahalingam, S., & Lidbury, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202415999 · Cited by 101
Lidbury, B. A., & Mahalingam, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8376-8381.2000 · Cited by 100
The enhancement of virus infectivity by antibody
Hawkes, R. A., & Lafferty, K. J. (1967) · Virology · doi:10.1016/0042-6822(67)90144-4 · Cited by 99
Schlesinger, J. J., & BRANDRISS, M. W. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.2.659 · Cited by 96
Hohdatsu, T., Nakamura, M., Ishizuka, Y., Yamada, H., & Koyama, H. (1991) · Archives of Virology · doi:10.1007/bf01310476 · Cited by 86
Baxt, B., & Mason, P. W. (1995) · Virology · doi:10.1006/viro.1995.1110 · Cited by 83
Antibody-Mediated Enhancement of Viral Disease
Sullivan, N. J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_8 · Cited by 79
C1q—how many functions? How many receptors?
Eggleton, P. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01373-7 · Cited by 79
Takeda, A., Sweet, R. W., & Ennis, F. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5605-5610.1990 · Cited by 76
Schutten, M., Andeweg, A. C., Bosch, M. L., & Osterhaus, A. D. M. E. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03528.x · Cited by 75
Perno, C. F., Baseler, M., Broder, S., & Yarchoan, R. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.4.1043 · Cited by 73
Montefiori, D. C., Robinson, W. E., Hirsch, V. M., Modliszewski, A., Mitchell, W. M., & Johnson, P. R. (1990) · Journal of Virology · doi:10.1128/jvi.64.1.113-119.1990 · Cited by 71
Krilov, L. R., Anderson, L. J., Marcoux, L., Bonagura, V. R., & Wedgwood, J. F. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.777 · Cited by 69
Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1
Ochiai, H., Kurokawa, M., Hayashi, K., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.20-26.1988 · Cited by 65
C1q-binding proteins and C1q receptors
Nicholson-Weller, A., & Klickstein, L. B. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80008-9 · Cited by 63
Kanno, H., Wolfinbarger, J. B., & Bloom, M. E. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7017-7024.1993 · Cited by 63
Ochiai, H., Kurokawa, M., Matsui, S., Yamamoto, T., Kuroki, Y., Kishimoto, C., & Shiraki, K. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890360312 · Cited by 61
In vitro Enhancement of Respiratory Syncytial Virus Infection of U937 Cells by Human Sera
Gimenez, H. B., Keir, H. M., & Cash, P. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-89 · Cited by 54
Antibody-mediated Enhancement of Rabies Virus Infection in a Mouse Macrophage Cell Line (P388D1)
King, A. A., Sands, J. J., & Porterfield, J. S. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-6-1091 · Cited by 46
Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain
Girn, J., Kavoosi, M., & Chantler, J. K. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-2-351 · Cited by 44
Trischmann, H., Davis, D. A., & Lachmann, P. J. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.343 · Cited by 38
Schlesinger, J. J., & BRANDRISS, M. W. (1981) · Journal of Medical Virology · doi:10.1002/jmv.1890080204 · Cited by 32
Schlesinger, J. J., & BRANDRISS, M. W. (1983) · Journal of General Virology · doi:10.1099/0022-1317-64-6-1255 · Cited by 29
Laurence, J. C., Saunders, A., Early, E., & Salmon, J. E. (1990) · PubMed · Cited by 27
Stoddart, C. A., & Scott, F. W. (1988) · Journal of Leukocyte Biology · doi:10.1002/jlb.44.5.319 · Cited by 26
Schutten, M., Osterhaus, A. D. M. E., Andeweg, A. C., & Rimmelzwaan, G. F. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-5-999 · Cited by 17
Cited by
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 788
Casagrande, M., Favieri, F., Tambelli, R., & Forte, G. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.05.011 · Cited by 735
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
CZUB, M., WEINGARTL, H., CZUB, S., HE, R., & CAO, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.033 · Cited by 180
Quinlan, B. D., Mou, H., Zhang, L., Guo, Y., He, W., Ojha, A., Parcells, M. S., Luo, G., Li, W., Zhong, G., et al. (2020) · doi:10.1101/2020.04.10.036418 · Cited by 140
Metadata
- Authors
- Takada, A., & Kawaoka, Y.
- Venue
- Reviews in Medical Virology
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 13
- Issue
- 6
- Pages
- 387-398
- ISSN
- 1052-9276 (ISSN-L)
- 1099-1654
- OpenAlex
- W1968895408
- Cited by
- 332
- References
- 58
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.